Beam Therapeutics Inc. Q1 Loss decreases, beats estimates

Beam Therapeutics Inc. (BEAM) reported Loss for first quarter that decreased from the same period last year and beat the Street estimates.

The company's bottom line totaled -$69.214 million, or -$1.01 per share. This compares with -$201.560 million, or -$3.35 per share, in last year's first quarter.

Analysts on average had expected the company to earn -$1.32 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 140433.3% to $8.432 million from $0.006 million last year.

Beam Therapeutics Inc. earnings at a glance (GAAP) :

-Earnings (Q1): -$69.214 Mln. vs. -$201.560 Mln. last year.
-EPS (Q1): -$1.01 vs. -$3.35 last year.
-Analyst Estimates: -$1.32
-Revenue (Q1): $8.432 Mln vs. $0.006 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT